|
www.aurobindo.com |
|
|
Hyderabad, April 26, 2007 |
|
|
|
Aurobindo receives Eighth approval
from MCC South
Africa |
|
|
Aurobindo Pharma Limited is
delighted to announce that it has received
another marketing authorization approval from
Medicines
Control Council (MCC) of South
Africa. The Council has approved Metformin
tablets in 500mg, 850mg and 1gm strengths. South
African market is highly regulated and very
important in its Geographical sphere. Aurobindo
having bagged this approval can now participate
in one of the key segments of South African
market. |
|
Metformin was originally
discovered by Bristol Myers Squibb, USA and
popularly known as Glucophage. It is mostly used
in Type 2 diabetes especially in obese and
insulin resistance cases. Metformin helps to
increase insulin sensitivity and decreases
absorption of glucose from gastro intestinal
tract. Aurobindo is already marketing Metformin
successfully in the USA. |
|
Metformin today commands a market
of 15mio USD in South Africa. |
|
About Aurobindo Pharma Limited: |
|
Aurobindo Pharma Limited (www.aurobindo.com),
headquartered at Hyderabad, India, manufactures
generic pharmaceuticals and active
pharmaceutical ingredients. The company’s robust
product portfolio is spread over 6 major
therapeutic/product areas encompassing
(Antibiotics, Anti-Retrovirals, CVS/ Statins/Diabetology,
CNS, Gastro/Uro/Kidney therapeutics, Anti
fungal/ allergics/respiratory)
The Company markets its products
in over 100 countries. The company has filed
over 86 ANDAs and 110 DMFs for the USA market,
in addition to several filings in other
countries. The company has received approvals
for several facilities from leading regulatory
agencies like US FDA, UK MHRA, WHO, Health
Canada, MCC South Africa. |
For further information,
please contact:
Investor Relations
Aurobindo Pharma Limited
Plot # 2, Maitri Vihar | Ameerpet
Hyderabad - 500 038 |India
Phone (Board): +91 40 6672 5000
Mobile 0 98486 67906
Email : ir@aurobindo.com |
|
|
|
|
|
|
|
|
|
PRESS
ROOM
